Zenara
India 182 employees Updated 9 July 2026
Zenara is a finished-dose manufacturer based in India. It appears in 24 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA, CDSCO (India) and MINSA (CR). Its GMP standing is certified by US FDA and MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 21 May 2024 as VAI.
1
registered plants
1 with an FDA FEI number
24
filings
across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Hyderabad, India | 3005485158 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | 18 | 1 |
| CDSCO (India) | 5 | None |
| MINSA (CR) | 1 | None |
| MHRA (UK) | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Zenara comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- 24 active litigation matters are on record.
- The most recent inspection outcome was VAI, on 21 May 2024.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates